Safadi R - Search Results

1

Amelioration of hepatic fibrosis by NK cell activation.

Muhanna N, Abu Tair L, Doron S, Amer J, Azzeh M, Mahamid M, Friedman S, Safadi R. Muhanna N, et al. Among authors: safadi r. Gut. 2011 Jan;60(1):90-8. doi: 10.1136/gut.2010.211136. Epub 2010 Jul 26. Gut. 2011. PMID: 20660699

2

Hepatic fibrosis--role of hepatic stellate cell activation.

Safadi R, Friedman SL. Safadi R, et al. MedGenMed. 2002 Jul 15;4(3):27. MedGenMed. 2002. PMID: 12466770 Free article. Review.

3

Treatment of hepatic fibrosis: almost there.

Albanis E, Safadi R, Friedman SL. Albanis E, et al. Among authors: safadi r. Curr Gastroenterol Rep. 2003 Feb;5(1):48-56. doi: 10.1007/s11894-003-0009-7. Curr Gastroenterol Rep. 2003. PMID: 12530948 Review.

4

Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes.

Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, Mehal WZ, Friedman SL. Safadi R, et al. Gastroenterology. 2004 Sep;127(3):870-82. doi: 10.1053/j.gastro.2004.04.062. Gastroenterology. 2004. PMID: 15362042

5

Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression.

Bansal MB, Kovalovich K, Gupta R, Li W, Agarwal A, Radbill B, Alvarez CE, Safadi R, Fiel MI, Friedman SL, Taub RA. Bansal MB, et al. Among authors: safadi r. J Hepatol. 2005 Apr;42(4):548-56. doi: 10.1016/j.jhep.2004.11.043. J Hepatol. 2005. PMID: 15763341 Free PMC article.

6

Enhanced oral tolerance in transgenic mice with hepatocyte secretion of IL-10.

Safadi R, Alvarez CE, Ohta M, Brimnes J, Kraus T, Mehal W, Bromberg J, Mayer L, Friedman SL. Safadi R, et al. J Immunol. 2005 Sep 15;175(6):3577-83. doi: 10.4049/jimmunol.175.6.3577. J Immunol. 2005. PMID: 16148101

7

Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking.

Gur C, Karussis D, Golden E, Doron S, Ilan Y, Safadi R. Gur C, et al. Among authors: safadi r. Clin Immunol. 2006 Feb-Mar;118(2-3):307-16. doi: 10.1016/j.clim.2005.10.004. Epub 2005 Nov 14. Clin Immunol. 2006. PMID: 16290121

8

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

Melhem A, Muhanna N, Bishara A, Alvarez CE, Ilan Y, Bishara T, Horani A, Nassar M, Friedman SL, Safadi R. Melhem A, et al. Among authors: safadi r. J Hepatol. 2006 Jul;45(1):60-71. doi: 10.1016/j.jhep.2005.12.025. Epub 2006 Feb 8. J Hepatol. 2006. PMID: 16515819

9

Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis.

Horani A, Muhanna N, Pappo O, Melhem A, Alvarez CE, Doron S, Wehbi W, Dimitrios K, Friedman SL, Safadi R. Horani A, et al. Among authors: safadi r. Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G628-38. doi: 10.1152/ajpgi.00137.2006. Epub 2006 Oct 12. Am J Physiol Gastrointest Liver Physiol. 2007. PMID: 17038628 Free article.

10

Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution.

Safadi R, Zigmond E, Pappo O, Shalev Z, Ilan Y. Safadi R, et al. Int Immunol. 2007 Aug;19(8):1021-9. doi: 10.1093/intimm/dxm069. Epub 2007 Aug 13. Int Immunol. 2007. Retraction in: Int Immunol. 2011 Jul;23(7):465. doi: 10.1093/intimm/dxr054 PMID: 17698563 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters